By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation
NCT ID: NCT03880721
Last Updated: 2019-05-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2019-01-01
2021-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Central Obesity and Hepatocellular Carcinoma
NCT03082378
Radiomics for Diagnosing Liver Diseases and Evaluating Progression
NCT03221049
Microwave Ablation Versus Liver Resection For Early Hepatocellular Carcinoma in Patients With Borderline Liver Function
NCT03766555
Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)
NCT07059936
Utility of Ultrasound Imaging for Diagnosis of Focal Liver Lesions: A Radiomics Analysis
NCT03871140
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Good prognosis
Microwave abaltion
Use microwave ablation to treat hepatocellular carcinoma
Poor prognosis
Microwave abaltion
Use microwave ablation to treat hepatocellular carcinoma
Recurrence
Microwave abaltion
Use microwave ablation to treat hepatocellular carcinoma
Not Recurrence
Microwave abaltion
Use microwave ablation to treat hepatocellular carcinoma
Survival
Microwave abaltion
Use microwave ablation to treat hepatocellular carcinoma
Death
Microwave abaltion
Use microwave ablation to treat hepatocellular carcinoma
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Microwave abaltion
Use microwave ablation to treat hepatocellular carcinoma
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Primary hepatocellular
2. No other treatments ware performed before microwave ablation
3. Patient has been clinically diagnosed with HCC definitely, and have a definite operational indication
4. No extrahepatic manifestations and no evidence of vessel invasion and bile duct thrombi
Exclusion Criteria
2. Accept other treatment before microwave ablation
3. Extrahepatic metastasis, vessel invasion or bile duct thrombi
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese PLA General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ping Liang
Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chinese PLA General Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ping Liang, Doctor
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
301jrcsk4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.